Indeed, Cumming and co-workers identified an inactive version of PRDX2 with an oxidized catalytic cysteine residue in the AD brains, while both oxidized and unoxidized PRDX2 were identified in the control brains [33]. This evidence concerns the gene PRDX2 and Alzheimer disease.